Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.
Kantarjian H, Short NJ, Jain N, Haddad FG, Kadia T, Yilmaz M, Ferrajoli A, Sasaki K, Alvarado Y, Pemmaraju N, Senapati J, Garris R, Ravandi F, Jabbour E. Kantarjian H, et al. Among authors: short nj. Am J Hematol. 2025 Jan 5. doi: 10.1002/ajh.27576. Online ahead of print. Am J Hematol. 2025. PMID: 39757533
Outcomes of Patients With Treated Secondary Acute Myeloid Leukemia: A High-Risk Subtype That Warrants an Independent Prognostic Designation.
Senapati J, Kantarjian HM, Haddad FG, Short NJ, Borthakur G, Kanagal-Shamanna R, Tang G, Jabbour E, DiNardo CD, Daver N, Montalban-Bravo G, Shah V, Alousi A, Shpall E, Popat U, Garcia-Manero G, Ravandi F, Kadia TM. Senapati J, et al. Among authors: short nj. Am J Hematol. 2025 Feb;100(2):249-259. doi: 10.1002/ajh.27561. Epub 2024 Dec 24. Am J Hematol. 2025. PMID: 39718824
Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms.
Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG. Senapati J, et al. Among authors: short nj. Haematologica. 2024 Dec 12. doi: 10.3324/haematol.2024.286465. Online ahead of print. Haematologica. 2024. PMID: 39665206 Free article.
Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy.
Jen WY, Sasaki K, Ravandi F, Kadia TM, Wang SA, Wang W, Loghavi S, Daver NG, DiNardo CD, Issa GC, Abbas HA, Nasnas C, Bataller A, Urrutia S, Karrar OS, Pierce SA, Kantarjian HM, Short NJ. Jen WY, et al. Among authors: short nj. Blood Adv. 2024 Dec 4:bloodadvances.2024013826. doi: 10.1182/bloodadvances.2024013826. Online ahead of print. Blood Adv. 2024. PMID: 39631072
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia.
Short NJ, Wierzbowska A, Cluzeau T, Laribi K, Recher C, Czyz J, Ochrem B, Ades L, Gallego-Hernanz MP, Heiblig M, Audisio E, Zarzycka E, Li S, Ferenc N, Yeh T, Faller DV, Sedarati F, Papayannidis C. Short NJ, et al. Leuk Lymphoma. 2024 Nov 28:1-11. doi: 10.1080/10428194.2024.2431878. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39606906 Free article.
Cladribine-Based Therapy for Acute Myeloid Leukemia in Child, Adolescent, and Early Young Adult Patients: The MD Anderson Cancer Center Experience.
McCall D, Alqahtani S, Budak M, Sheikh I, Fan AE, Ramakrishnan R, Nunez C, Roth M, Garcia MB, Gibson A, Daver N, Garces S, Short NJ, Issa GC, Ravandi F, DiNardo CD, Montalban Bravo G, Garcia-Manero G, Cuglievan B, Kadia T. McCall D, et al. Among authors: short nj. Cancers (Basel). 2024 Nov 20;16(22):3886. doi: 10.3390/cancers16223886. Cancers (Basel). 2024. PMID: 39594839 Free PMC article.
Long-term follow-up of a phase 2 study of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in acute promyelocytic leukemia.
Jen WY, Marvin-Peek J, Kantarjian HM, Alvarado Y, Borthakur G, Jabbour E, Wierda W, Kadia TM, Daver NG, DiNardo CD, Short NJ, Jain N, Ferrajoli A, Kornblau S, Yilmaz M, Ohanian M, McCue D, Burger J, Hammond D, Patel K, Issa GC, Pemmaraju N, Sasaki K, Maiti A, Abbas HA, Chien K, Takahashi K, Haddad F, Bose P, Masarova L, Montalban-Bravo G, Swaminathan M, Brandt M, Pierce S, Garcia-Manero G, Ravandi F. Jen WY, et al. Among authors: short nj. Cancer. 2025 Jan 1;131(1):e35662. doi: 10.1002/cncr.35662. Epub 2024 Nov 25. Cancer. 2025. PMID: 39584789 Clinical Trial.
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: short nj. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
281 results